Inventor · disambiguated record
Jeremy Lee Baryza
Also filed as: BARYZA JEREMY · BARYZA JEREMY L · BARYZA JEREMY LEE
17 granted patents·5 pending applications·191 citations·filing 1998–2019
93Inventor score
Files withNOVARTIS AG7BAYER PHARMACEUTICALS CORP4BARYZA JEREMY LEE3ARROWHEAD PHARMACEUTICALS INC2BAYER AG2
Top patents by PatentIndex Score
22 records- 0193US6787651B2Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agentsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 7, 2004·72 cites·14 claims
- 0292US9504747B2Lipids and lipid compositions for the delivery of active agentsBARYZA JEREMY LEE·Filed 2014·Granted Nov 29, 2016·10 cites·21 claims
- 0390US10240153B2Organic compositions to treat APOC3-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Mar 26, 2019·7 cites·17 claims
- 0489US9301923B2Lipids, lipid compositions, and methods of using themBARYZA JEREMY·Filed 2014·Granted Apr 5, 2016·28 cites·8 claims
- 0586US6784167B217-beta-hydroxysteroid dehydrogenase-II inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·35 cites·17 claims
- 0685US10124065B2Lipids and lipid compositions for the delivery of active agentsNOVARTIS AG·Filed 2014·Granted Nov 13, 2018·8 cites·21 claims
- 0785US9988627B2Formats for organic compounds for use in RNA interferenceBARYZA JEREMY LEE·Filed 2014·Granted Jun 5, 2018·9 cites·21 claims
- 0877US11066667B2Organic compositions to treat APOC3-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Jul 20, 2021·1 cites·18 claims
- 0971US6051586ASulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonistsBAYER AG·Filed 1998·Granted Apr 18, 2000·12 cites·11 claims
- 1068US10729775B2Lipids and lipid compositions for the delivery of active agentsNOVARTIS AG·Filed 2018·Granted Aug 4, 2020·0 cites·21 claims
- 1165US10519446B2Organic compounds to treat hepatitis B virusNOVARTIS AG·Filed 2014·Granted Dec 31, 2019·1 cites·14 claims
- 1261US11008570B23′ end caps for RNAi agents for use in RNA interferenceNOVARTIS AG·Filed 2019·Granted May 18, 2021·0 cites·20 claims
- 1359US2017196979A1Lipids and lipid compositions for the delivery of active agentsBARYZA JEREMY LEE·Filed 2016·Application pending·0 cites
- 1455US10227588B23′end caps for RNAi agents for use in RNA interferenceNOVARTIS AG·Filed 2014·Granted Mar 12, 2019·0 cites·18 claims
- 1552US6903218B2Sulfonamide substituted chroman derivativesBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jun 7, 2005·0 cites·5 claims
- 1650US10792361B2Lipids and lipid compositions for the delivery of active agentsNOVARTIS AG·Filed 2018·Granted Oct 6, 2020·0 cites·1 claims
- 1749US6797714B2Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Sep 28, 2004·0 cites·10 claims
- 1846US6469031B1Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonistsBAYER AG·Filed 1998·Granted Oct 22, 2002·8 cites·11 claims
- 1945US2003073839A1Compounds useful for preparation of Beta-3 adrenoreceptor agonistFiled 2000·Application pending·0 cites
- 2043US2011200582A1Lipids, lipid compositions, and methods of using themNOVARTIS AG·Filed 2010·Application pending·0 cites
- 2141US2005119246A11H-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptorBAYER PHARMACEUTICALS CORP·Filed 2002·Application pending·0 cites
- 2240US2005119489A14-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptorFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeremy Lee Baryza files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →